MHRA (Medicines and Healthcare Products Regulatory Agency) ran a consultation on the continued availability of diclofenac as a Pharmacy (P) medicine and on the risk minimisation…
The Home Office ran a consultation on the scheduling of tramadol under the Misuse of Drugs Regulations 2001. This followed a Ministerial decision, in principle, to accept the ACMD's…
The European Medicines Agency (EMA) ran a consultation to discuss their proposed policy for access to clinical trial data for data submitted to the EMA from January 2014. BPS noted…
The Commons Select Science and Technology Committee held an inquiry on the ‘leaky pipeline’ i.e. the continuous loss of women at consecutive career stages within STEM industries. The…
The Society responded to the Ethical Standards in the Health & Life Sciences Group’s (ESHLSG) consultation to highlight our support for declaration of payments made to healthcare…
The Finch Group met in September 2013 to review progress in implementing the recommendations from the report. In order to inform this review meeting, we responded to the Society of…
John O’Reilly, the Director General for Knowledge and Innovation at the Department for Business, Innovation & Skills (BIS) requested views and comments on the key priorities and…
Higher Education Funding Council for England (HEFCE) invited advice from stakeholders to develop the four UK funding bodies’ joint policy on open access in the post-2014 Research…
The House of Lords Science & Technology Committee recommended the Research Council UK’s (RCUK) policy on open access be revised to improve the clarity of the policy. The…
The Society welcomes the additions to the NHS Constitution regarding patient data that make clear patients’ legal rights. Changes to the NHS Constitution represent an important step…
